DE602004013644D1 - Kristalline alfuzosinbase - Google Patents

Kristalline alfuzosinbase

Info

Publication number
DE602004013644D1
DE602004013644D1 DE602004013644T DE602004013644T DE602004013644D1 DE 602004013644 D1 DE602004013644 D1 DE 602004013644D1 DE 602004013644 T DE602004013644 T DE 602004013644T DE 602004013644 T DE602004013644 T DE 602004013644T DE 602004013644 D1 DE602004013644 D1 DE 602004013644D1
Authority
DE
Germany
Prior art keywords
crystalline
base
hours
alfuzosine
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004013644T
Other languages
English (en)
Inventor
Reddy Bandi Parthasaradhi
Reddy Kura Rathnakar
Reddy Rapolu Raji
Reddy Dasari Muralidhara
Reddy Matta Ramakrishna
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hetero Drugs Ltd
Original Assignee
Hetero Drugs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hetero Drugs Ltd filed Critical Hetero Drugs Ltd
Publication of DE602004013644D1 publication Critical patent/DE602004013644D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Silicon Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DE602004013644T 2004-09-16 2004-09-16 Kristalline alfuzosinbase Expired - Lifetime DE602004013644D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IN2004/000292 WO2006030449A1 (en) 2004-09-16 2004-09-16 Crystalline alfuzosin base

Publications (1)

Publication Number Publication Date
DE602004013644D1 true DE602004013644D1 (de) 2008-06-19

Family

ID=36059740

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004013644T Expired - Lifetime DE602004013644D1 (de) 2004-09-16 2004-09-16 Kristalline alfuzosinbase

Country Status (7)

Country Link
US (1) US20070100143A1 (de)
EP (1) EP1789412B1 (de)
AT (1) ATE394395T1 (de)
DE (1) DE602004013644D1 (de)
ES (1) ES2305848T3 (de)
PL (1) PL1789412T3 (de)
WO (1) WO2006030449A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005019227A1 (en) * 2003-08-22 2005-03-03 Orchid Chemicals & Pharmaceuticals Ltd Process for the preparation of cephalosporin antibiotic
WO2006090268A2 (en) * 2005-02-28 2006-08-31 Glenmark Pharmaceuticals Limited Processes for the preparation of alfuzosin and salts thereof and novel crystalline forms of alfuzosin
US20070105880A1 (en) * 2005-11-08 2007-05-10 Torrent Pharmaceuticals Limited Process for the preparation of alfuzosin
US20090069562A1 (en) * 2005-12-26 2009-03-12 Joseph Prabahar Koilpillai Process for the preparation of alfuzosin
WO2008015525A2 (en) * 2006-07-31 2008-02-07 Orchid Chemicals & Pharmaceuticals Limited An improved process for the preparation of alfuzosin hydrochloride
WO2007063556A2 (en) * 2006-12-07 2007-06-07 Msn Laboratories Limited An improved and industrial process for the preparation of alfuzosin hydrochloride and its novel polymorphs
EP2152697A2 (de) 2007-05-04 2010-02-17 Actavis Group PTC EHF Verfahren zur herstellung von alfuzosin und salzen daraus
IT1390760B1 (it) * 2008-07-21 2011-09-23 Lundbeck Pharmaceuticals Italy Spa Metodo di preparazione di alfuzosin cloridrato anidro
CN108069945A (zh) * 2017-12-31 2018-05-25 威海贯标信息科技有限公司 一种阿夫唑嗪新晶型
CN114874223B (zh) * 2022-05-25 2023-12-22 宁夏东吴农化股份有限公司 一种从噁二嗪废水中提取乌洛托品的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2421888A1 (fr) * 1978-02-06 1979-11-02 Synthelabo Amides d'alkylene-diamines et leur application en therapeutique
US4354921A (en) * 1981-07-27 1982-10-19 Texaco Inc. Solvent dewaxing process
US4668768A (en) * 1985-11-25 1987-05-26 General Electric Company Anti-solvent precipitation process for isolating polymers from solution
JPH07206857A (ja) * 1993-12-28 1995-08-08 Synthelabo Sa アルフゾシン塩酸塩の二水和物
US7927613B2 (en) * 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
GB0605688D0 (en) * 2006-03-21 2006-05-03 Novartis Ag Organic compounds
US7923026B2 (en) * 2006-10-20 2011-04-12 Solvay Pharmaceuticals B.V. Embedded micellar nanoparticles

Also Published As

Publication number Publication date
WO2006030449A1 (en) 2006-03-23
PL1789412T3 (pl) 2008-10-31
EP1789412A1 (de) 2007-05-30
US20070100143A1 (en) 2007-05-03
ATE394395T1 (de) 2008-05-15
EP1789412B1 (de) 2008-05-07
ES2305848T3 (es) 2008-11-01

Similar Documents

Publication Publication Date Title
CA2555804A1 (en) Polymorphic form of imatinib mesylate and a process for its preparation
CA2610105C (en) Process for the synthesis of organic compounds
US9115112B2 (en) Aminoanthracene derivative and an organic electroluminescent element employing the same
ATE394395T1 (de) Kristalline alfuzosinbase
JP2005179362A5 (de)
NZ592533A (en) METHOD FOR THE PREPARATION OF N-(5-CHLORO-2-PYRIDINYL)-2-[[4-[(DIMETHYLAMINO) IMINOMETHYL] BENZOYL] AMINO]-5-METHOXY-BENZAMIDE, A FACTOR Xa INHIBITOR
MX2008008447A (es) Proceso para la preparacion de imatinib.
CN110408383B (zh) 具有扭曲给-受体结构的纯有机室温磷光材料及其制备方法和应用
WO2007062002A3 (en) Fluorescent brighteners and compositions thereof, methods of preparation and uses
NO20052781L (no) Forbindelser og prosesser
TW200726750A (en) Stilbene derivatives, light-emitting element and light-emitting device
BR0211826A (pt) Imidazopiridinas tricìclicas
DK1907396T3 (da) Fremgangsmåde til fremstilling af 4-beta-amino-4'-demethyl-4-deoxypodophyllotoxin
NO20080648L (no) Syntesemetoder med hoyt utbytte for fremstilling av organiske salter av strontium
MX2007004638A (es) Proceso para la preparacion de pirazoles.
MX2009010243A (es) Compuestos de quinolina apropiados para tratar trastornos que responden a la modulacion del receptor de serotonina 5-ht6.
TWI371449B (en) Conversion of 2-pyrazolines to ryrazoles using bromine
TW200609203A (en) Preparation of semicarbazones
MX2008000011A (es) Procesos para preparar derivados de pirazol-o-glucosido y nuevos intermediarios de dichos procesos.
ES2452940T3 (es) Procedimiento novedoso de preparación de base de imatinib
WO2005080329A3 (en) Process for manufacture of racemic carvedilol
EA200601106A1 (ru) Трициклические имидазопиридины для применения в качестве ингибиторов желудочной секреции
DK1558560T3 (da) Fremgangsmåde til fremstilling af 2,6-dihalogen-para-trifluormenthylanilin
IL149526A0 (en) Process for the preparation of ketimines
JP2003512370A5 (de)

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: HANSMANN & VOGESER, 81369 MUENCHEN

8364 No opposition during term of opposition